# Donated Antibodies Working Against nCoV

> **NCT04429854** · PHASE2 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 483 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Convalescent Plasma
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT04429854
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-02
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 483 (ACTUAL)
- **Last updated:** 2021-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04429854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04429854, "Donated Antibodies Working Against nCoV". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04429854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*